The global chronic wound care market is poised for significant growth, with a projected rise at a Compound Annual Growth Rate (CAGR) of 3.8% from 2023 to 2033. The market value is forecasted to increase from an estimated USD 17,272.4 million in 2023 to USD 25,042.5 million by 2033, driven by increasing demand for advanced wound care treatments and innovative technologies.
In 2022, the global chronic wound care market was valued at USD 16,689.3 million, marking a strong foundation for continued expansion. This growth trajectory is expected to further accelerate with a year-over-year growth rate of 3.5% in 2023. The surge in the market can be attributed to the rising incidence of chronic wounds, particularly those resulting from diabetes, vascular diseases, and aging populations worldwide.
As chronic wounds continue to present a significant healthcare challenge, the market for wound care solutions is responding with enhanced treatment options. Technological advancements in wound care materials, including hydrocolloid and hydrogel dressings, as well as the growing adoption of advanced therapies such as negative pressure wound therapy (NPWT) and bioengineered skin substitutes, are expected to contribute to the market’s growth.
The global chronic wound care market is expected to experience a promising outlook, driven by innovation and the increasing focus on improving patient outcomes. As the healthcare industry continues to evolve, companies within this market will play a pivotal role in addressing the pressing need for effective and efficient wound care solutions.
Key Takeaways:
- The global chronic wound care market is set to grow at a CAGR of 3.8% from 2023 to 2033, with the market value expected to rise from USD 17,272.4 million in 2023 to USD 25,042.5 million by 2033.
- The United States is the dominant player in the chronic wound care market, holding a 34.9% share in 2022. This dominance is driven by the growing prevalence of chronic wounds linked to conditions such as diabetes, obesity, and vascular diseases. The market in North America is expected to grow at a modest CAGR of 1.2% during the forecast period.
- China is also showing substantial market potential, with government reforms improving healthcare access and quality. These reforms are expected to boost the demand for chronic wound care products in the country, supported by a growing pharmaceutical market.
- India’s market share of 4.1% in 2022 is projected to rise due to increasing prevalence of chronic conditions, heightened awareness among healthcare professionals and patients, and a greater focus on early intervention and advanced wound care treatments.
- In Germany, demand for chronic wound care is growing, driven by specialized treatment centers, awareness campaigns, and the adoption of advanced wound care technologies, such as antibacterial dressings. The trend of telemedicine and remote monitoring is also gaining traction.
- Japan is set to see a 4.8% CAGR due to its aging population and rising chronic conditions. Innovation in wound care technologies, government funding for bioengineering, and increasing demand for home healthcare will further drive growth. Strict regulations ensure a high standard of quality and safety for wound care products.
Overall, the market is being shaped by rising healthcare awareness, government initiatives, and technological advancements, with strong growth expected in both developed and emerging markets.
“As diabetic ulcers become more prevalent and new drugs and devices are approved, artificial intelligence and technology are expected to play a significant role in growing sensor-based bandages.” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI) analyst.
Competitive Landscape:
Collaboration across various healthcare disciplines—such as surgeons, nurses, microbiologists, and researchers—plays a vital role in enhancing patient outcomes and promoting the adoption of innovative wound care solutions, including antimicrobial dressings.
To solidify their position in the market, industry players are employing a range of strategies, including collaborations, mergers and acquisitions, and new product launches. Additionally, leading companies are heavily investing in research and development to introduce cutting-edge products and advanced technologies.
Notable recent developments include:
- In April 2022, Lupin acquired Anglo-French brands.
- Teva Pharmaceuticals reached a settlement with the Attorney General of Rhode Island in March 2022 regarding opioid-related claims by the state and its subdivisions.
- In January 2023, Mimedx and Gunze Medical Limited entered into an exclusive distribution agreement to offer Epifix, an allogeneic placental tissue for wound healing, in Japan.
Key Companies Profiled:
Teva Pharmaceuticals; Lupin Ltd; Cipla Ltd; MTF Biologics; MIMEDX Group, Inc.; Integra Lifesciences; Smith and Nephew plc; Cardinal Health Inc.; 3M; Mölnlycke Health Care; Medline Industries, Inc.; ConvaTec Group plc.; Coloplast Corp.; B. Braun Holding GmbH & Co. KG; Johnson & Johnson Innovation, LLC; Stryker Corporation; Anika Therapeutics, Inc.; Becton, Dickinson and Company; Novartis AG; Perrigo Company plc; AstraZeneca; Essity AB (BSN Medical); Boen Healthcare Co., Ltd; Hakuzo Medical Asia Co., Ltd; Organogenesis Holdings Inc.; PAUL HARTMANN AG; Alleva Medical Ltd. (Devon Medical Products); Olle Larsson Holding AG (Medela AG); Avery Dennison Corporation; Oneness Biotech; Vericel Corporation; Marine Polymer Technologies Inc.; SIGVARIS GROUP; Taro Pharmaceuticals; Prasco Laboratories.
Chronic Wound Care Market Outlook by Category:
By Product:
- Advanced Wound Dressings
- Antimicrobial Dressings
- Silver Dressings
- Non-Silver Dressings
- Foam Dressings
- Silicon
- Non-Silicon Dressings
- Hydrogels Dressings
- Semi-Permeable Films Dressings
- Alginate Dressings
- Hydrocolloid Dressings
- Collagen Dressing
- Contact Layer
- Honey Dressings
- Super Absorbent Dressings
- Other
- Antimicrobial Gels
- Antimicrobial Powder
- Concentrated Surfactant
- Skin Protectants
- Wound Cleansers
- Unna Boots
- Tapes
- Antimicrobial Dressings
- Drugs
- Topical Drug
- Becaplermin
- Gentamicin
- Minocycline
- Lidocaine
- Sulfadiazine
- Others
- Oral Drugs
- Colchicine
- Prednisolone
- Aspirin
- Anticoagulants
- Warfarin
- Others
- Topical Drug
- Biologics
- Biological Skin Substitutes
- Biomembranes
- Negative Pressure Wound Therapy (NPWT) Devices
- Standalone NPWT Devices
- Disposable NPWT Devices
- Portable NPWT Devices
- NPWT Accessories (Canister)
By Wound Type:
- Diabetic Foot Ulcers
- Venous Ulcers
- Pressure Ulcers
- Other Ulcers
By Distribution Channel:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Long-Term Care Centers
- Retail Pharmacies and Drug Stores
- Hypermarkets and Supermarkets
- Online Sales
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia and Pacific
- Central Asia
- Russia and Belarus
- Balkan and Baltic Countries
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube